bioAffinity Technologies, Inc. (BIAF)
2.15
+0.22
(+11.40%)
USD |
NASDAQ |
Nov 18, 16:00
2.08
-0.07
(-3.26%)
After-Hours: 20:00
bioAffinity Technologies Price to Book Value : 0.6407 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 0.6407 |
| November 17, 2026 | 0.5752 |
| November 16, 2026 | 0.596 |
| November 13, 2026 | 0.6556 |
| November 12, 2026 | 0.6973 |
| November 11, 2026 | 0.7227 |
| November 10, 2026 | 0.7123 |
| November 09, 2026 | 0.6735 |
| November 06, 2026 | 0.8091 |
| November 05, 2026 | 0.7748 |
| November 04, 2026 | 0.8732 |
| November 03, 2026 | 0.9507 |
| November 02, 2026 | 0.8911 |
| October 30, 2026 | 0.8672 |
| October 29, 2026 | 0.903 |
| October 28, 2026 | 0.9358 |
| October 27, 2026 | 0.8821 |
| October 26, 2026 | 0.8434 |
| October 23, 2026 | 0.8344 |
| October 22, 2026 | 0.9447 |
| October 21, 2026 | 1.064 |
| October 20, 2026 | 1.091 |
| October 19, 2026 | 1.046 |
| October 16, 2026 | 1.112 |
| October 15, 2026 | 1.180 |
| Date | Value |
|---|---|
| October 14, 2026 | 1.061 |
| October 13, 2026 | 1.080 |
| October 12, 2026 | 1.162 |
| October 09, 2026 | 1.408 |
| October 08, 2026 | 1.681 |
| October 07, 2026 | 1.836 |
| October 06, 2026 | 1.806 |
| October 05, 2026 | 1.845 |
| October 02, 2026 | 1.804 |
| October 01, 2026 | 1.831 |
| September 30, 2026 | 1.955 |
| September 29, 2026 | 0.8255 |
| September 28, 2026 | 0.8891 |
| September 25, 2026 | 0.9515 |
| September 24, 2026 | 0.9395 |
| September 23, 2026 | 0.9527 |
| September 22, 2026 | 1.026 |
| September 21, 2026 | 0.9239 |
| September 18, 2026 | 1.132 |
| September 17, 2026 | 1.050 |
| September 16, 2026 | 0.6419 |
| September 15, 2026 | 0.7631 |
| September 14, 2026 | 0.9515 |
| September 11, 2026 | 0.9539 |
| September 10, 2026 | 1.127 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 1.326 |
| Perspective Therapeutics, Inc. | 0.3022 |
| MiMedx Group, Inc. | 2.198 |
| Veracyte, Inc. | 1.439 |
| T2 Biosystems, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 0.1794 |
| Price | 2.15 |
| Earnings Yield | -1.77K% |
| Market Cap | 2.508M |